These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9829759)

  • 21. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
    Lund LH; Andersson K; Zuber B; Karlsson A; Engström G; Hinkula J; Wahren B; Winberg G
    Cancer Gene Ther; 2003 May; 10(5):365-76. PubMed ID: 12719706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells pulsed with an anti-idiotype antibody mimicking carcinoembryonic antigen (CEA) can reverse immunological tolerance to CEA and induce antitumor immunity in CEA transgenic mice.
    Saha A; Chatterjee SK; Foon KA; Primus FJ; Sreedharan S; Mohanty K; Bhattacharya-Chatterjee M
    Cancer Res; 2004 Jul; 64(14):4995-5003. PubMed ID: 15256474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z; Chen WS; Zhang HH; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
    Schirmbeck R; Reimann J
    Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single dose of oral DNA immunization delivered by attenuated Salmonella typhimurium down-regulates transgene expression in HBsAg transgenic mice.
    Zheng BJ; Ng MH; Chan KW; Tam S; Woo PC; Ng SP; Yuen KY
    Eur J Immunol; 2002 Nov; 32(11):3294-304. PubMed ID: 12555675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [C3d enhances the immune response against HBV-preS2/S following gene immunization in mice].
    Guan QD; Wang LX; Guo Q; Zhang JP; Xu W; Wang Y; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):101-5. PubMed ID: 15774215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of eukaryotic expression plasmids inserting HBsAg gene and DNA immunization responses to HBsAg in mice].
    Liang Z; Lan Y; Li Y; Cai D; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):106-8. PubMed ID: 11983125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects.
    Grosenbach DW; Barrientos JC; Schlom J; Hodge JW
    Cancer Res; 2001 Jun; 61(11):4497-505. PubMed ID: 11389081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis of augmented immune responses in mouse by prime-and-boost immunization strategy with DNA vaccine coding HBsAg and rHBsAg protein.
    Wang Y; Li DA; Hey Y; Wang F; Guo YJ; Yang F; Zhou Q; Sun SH
    Vaccine; 2007 Nov; 25(48):8146-53. PubMed ID: 18029065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
    Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of immunization with dendritic cells modified with fowlpox encoding carcinoembryonic antigen and costimulatory molecules.
    Morse MA; Clay TM; Hobeika AC; Osada T; Khan S; Chui S; Niedzwiecki D; Panicali D; Schlom J; Lyerly HK
    Clin Cancer Res; 2005 Apr; 11(8):3017-24. PubMed ID: 15837756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine.
    Huang Y; Fayad R; Smock A; Ullrich AM; Qiao L
    Cancer Res; 2005 Aug; 65(15):6990-9. PubMed ID: 16061685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles.
    March JB; Clark JR; Jepson CD
    Vaccine; 2004 Apr; 22(13-14):1666-71. PubMed ID: 15068849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine.
    Schirmacher V; Förg P; Dalemans W; Chlichlia K; Zeng Y; Fournier P; von Hoegen P
    Gene Ther; 2000 Jul; 7(13):1137-47. PubMed ID: 10918481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
    Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
    Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
    Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
    Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
    He X; Jiang L; Wang F; Xiao Z; Li J; Liu LS; Li D; Ren D; Jin X; Li K; He Y; Shi K; Guo Y; Zhang Y; Sun S
    J Control Release; 2005 Oct; 107(2):357-72. PubMed ID: 16099068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor immunity and prolonged survival following combined adenovirus-HSP72 and CEA-plasmid vaccination.
    Myers AL; Krewet JA; Shah MR
    Vaccine; 2005 May; 23(27):3565-71. PubMed ID: 15855015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.